<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04096300</url>
  </required_header>
  <id_info>
    <org_study_id>IMUEC396</org_study_id>
    <nct_id>NCT04096300</nct_id>
  </id_info>
  <brief_title>An Integrative Approach for Idiopathic Granulomatous Mastitis.</brief_title>
  <acronym>IIGM</acronym>
  <official_title>Traditional and Complementary Medicine: a Cure for Idiopathic Granulomatous Mastitis?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medipol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medipol University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Collaboration is established between Turkish Holistic &amp; Integrative Medicine Association and
      Traditional &amp; Complementary Medicine Society of Istanbul Medipol University.

      Study is carried out on idiopathic granulomatous mastitis patients who are followed in the
      Breast Clinic at Istanbul Medipol University Hospital for between September 2015 and
      September 2019. Hirudotherapy and medical cupping therapy were applied as traditional and
      complementary medicine integratively.

      Following initial radiological imaging, microbiological- and histological testing, side
      effects and relapses are analyzed. Follow-up examination is also carried out at the end of
      the treatment, which consisted of clinical breast exam and radiological imaging.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 1, 2019</start_date>
  <completion_date type="Anticipated">September 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change of Breast Mass Size</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>Ultrasonic scan at 6 months</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of Breast Mass Size</measure>
    <time_frame>Up to 48 months</time_frame>
    <description>Ultrasonic scan at 12 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of Breast Mass Size</measure>
    <time_frame>Up to 48 months</time_frame>
    <description>MRI scan at 12 months, if prompted by ultrasonic scan</description>
  </secondary_outcome>
  <enrollment type="Actual">30</enrollment>
  <condition>Idiopathic Granulomatous Mastitis</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Biopsy Samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients receiving Traditional and Complementary Medicine (T&amp;CM) for IGM will be
        retrospectively analyzed.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  IGM patients, either ones newly diagnosed or had previously received different types
             of treatments, currently refusing conventional treatments with immunosuppressives etc,
             or/and surgical management, and now und

        Exclusion Criteria:

          -  Patients currently using any conventional treatment, and/or contraindication to
             hirudotherapy and cupping.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Medipol University</name>
      <address>
        <city>Beykoz</city>
        <state>Istanbul</state>
        <zip>34810</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 16, 2019</study_first_submitted>
  <study_first_submitted_qc>September 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 19, 2019</study_first_posted>
  <last_update_submitted>September 18, 2019</last_update_submitted>
  <last_update_submitted_qc>September 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medipol University</investigator_affiliation>
    <investigator_full_name>Mujgan Cali≈ükan</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Integrative Medicine</keyword>
  <keyword>Ethnomedicine</keyword>
  <keyword>Hirudotherapy</keyword>
  <keyword>Idiopathic Granulomatous Mastitis</keyword>
  <keyword>Medical Cupping Therapy</keyword>
  <keyword>Traditional and Complementary Medicine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mastitis</mesh_term>
    <mesh_term>Granulomatous Mastitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

